Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den hoed cancer center

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 189-195

  Al Mamgani, Abrahim ^a   Van Rooij, Peter ^a   Verduijn, Gerda M ^a   Meeuwis, Cees A ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Head and neck cancer; Parotid carcinoma; Quality of life; Radiotherapy; Toxicity

Indexed keywords

AFTER-TREATMENT; CAUSE-SPECIFIC SURVIVAL; CUMULATIVE INCIDENCE; DISEASE-FREE SURVIVAL; DISTANT METASTASIS; END POINTS; FACIAL PARALYSIS; HEAD-AND-NECK CANCER; HISTOLOGICAL TYPE; KAPLAN-MEIER ESTIMATES; LOCOREGIONAL CONTROL; LONG-TERM OUTCOME; MULTI VARIATE ANALYSIS; NODE-NEGATIVE; OVERALL SURVIVAL; PAROTID CARCINOMA; PERINEURAL INVASION; POSTOPERATIVE RADIOTHERAPY; QUALITY OF LIFE; REGIONAL FAILURES; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

DISEASE CONTROL; DISEASES; PATHOLOGY; SURGERY; TOXICITY;

RADIOTHERAPY;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUCOEPIDERMOID TUMOR; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; CARCINOMA; CARCINOMA, ACINAR CELL; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NETHERLANDS; PAROTID GLAND; PAROTID NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865696131     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.045     Document Type: Article

References (11)

1. Dutch Association of Comprehensive Cancer Centres. Oncoline: Cancer clinical practice guidelines. Website. Available at: http://www.oncoline.nl/ uploaded/FILES/Grote%20speekselklieren/066hh.pdf. Accessed Nov 21, 2011.
2. S. Pohar, H. Gay, and P. Rosenbaum Malignant parotid tumors: Presentation, clinical/pathological prognostic factors, and treatment outcomes Int J Radiat Oncol Biol Phys 61 2005 112 118
3. W.M. Mendenhall, C.G. Morris, and R.J. Amdur Radiotherapy alone or combined with surgery for salivary gland carcinoma Cancer 102 2005 2544 2550
4. C.H.J. Terhaard, H. Lubsen, and C.R.N. Rasch The role of radiotherapy in the treatment of malignant salivary gland tumors Int J Radiat Oncol Biol Phys 61 2005 103 111
5. P. Levendag, A. Al-Mamgani, and D. Teguh Contouring in head and neck cancer 1st ed. 2009 Elsevier Munich p. 183
6. K. Bjordal, A. de Graeff, and P.M. Fayers A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group Eur J Cancer 36 2000 1796 1807
7. C.H.J. Terhaard, H. Lubsen, and I. Van der Tweel Salivary gland carcinoma: Independent prognostic factors for locoregional control, distant metastases and overall survival: Results of the Dutch Head-and-Neck Oncology Cooperative Group Head Neck 26 2004 681 693
8. M.H. Valstar, M.W.M. van den Berkel, and L.E. Emeele Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: A systemic review of the literature Head Neck 10 2010 1402 1411
9. J. Petsuksiri, A. Sermsree, and K. Thephamongkhol Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients Radiat Oncol 6 2011 19
10. Schoenfeld JD, Sher DJ, Norris CM, et al. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. Int J Radiat Oncol Biol Phys. In press.
11. Vander Poorten V, Bradley PJ, Takes RP, et al. Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology. Head Neck. In press.